Skip to content
Dr Lalchandani Labs logo

Dr Lalchandani Labs

541299 BSE
Price unavailable

Dr Lalchandani Labs (DLCL) share price was ₹7.07 at the 28 Oct 2026 close; market capitalisation ₹6.13 Cr; sector Healthcare Services. The share price fell 57.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue fell 8.6% year on year to ₹2.13 Cr and net profit was −₹0.13 Cr, against ₹0.27 Cr a year earlier (compared with Mar 2025). Promoters held 32.90% of Dr Lalchandani Labs in Mar 2026, up 1.75 percentage points from Sep 2025.

Close 28 Oct 2026 ₹7.07 −9.50 −57.33% 1Y

Key Fundamentals

SMEHealthcare ServicesHealthcare
Market Cap
₹6.13 Cr
EBITDA
₹69.00 L
Return on Equity
4.19%
Debt to Equity
0.15
Book Value
₹16.37
EPS (TTM)
—
52W High
₹17.99
52W Low
₹5.81

Price-based figures as of 28 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,906.1058.9431,994 Cr12.750.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,440.2079.0014,834 Cr15.500.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹548.3056.3511,371 Cr7.570.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹516.8046.648,226 Cr16.042.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.35150.446,339 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹319.1046.381,662 Cr6.790.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹494.7516.231,605 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Dr Lalchandani Labs (this company)
——6 Cr0.430.00%4.19%4.83%——
Median 8 companies₹548.3056.357,282 Cr7.180.21%12.72%15.22%894 Cr176 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

2
  • Company has reduced debt.
  • Stock is trading at 0.40 times its book value

Weaknesses

7
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -15.6% over past five years.
  • Promoter holding is low: 32.9%
  • Company has a low return on equity of -1.29% over last 3 years.
  • Company has high debtors of 532 days.
  • Promoter holding has decreased over last 3 years: -27.9%
  • Working capital days have increased from 260 days to 461 days

Technical Indicators

Oscillators

Bullish

Bearish
0
Neutral
7
Bullish
2

Overall

Bearish

Bearish
10
Neutral
7
Bullish
2

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
-6.89% lower than 3Y

change over 1 year

Net Income Growth
-92.5% lower than 3Y

change over 1 year

Cash Flow Change
268%

change over 1 year

EBITDA Margin Change
-21.05%

change over 1 year Operating margin 6.1% · Mar 2026

Quarterly Results

Particulars Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
3.07
2.71
7.07
8.02
3.26
2.28
2.76
2.73
2.08
2.13
2.33
2.05
2.13
Expenses
2.53
2.14
5.4
6.07
2.81
2.46
2.5
2.38
1.04
1.59
1.82
1.79
2
Operating Profit
0.54
0.57
1.67
1.95
0.45
-0.18
0.26
0.35
1.04
0.54
0.51
0.26
0.13
OPM %
17.59%
21.03%
23.62%
24.31%
13.8%
-7.89%
9.42%
12.82%
50%
25.35%
21.89%
12.68%
6.1%
Other Income
0
0
0
0
0
0.01
0
0
0.24
0
0
0.29
0
Interest
0.09
0.05
0.3
0.24
0.33
0.48
0.51
0.11
0.28
0.05
0.03
0.01
0.01
Depreciation
0.22
0.23
0.29
0.28
0.3
0.33
0.34
0.33
0.29
0.28
0.28
0.28
0.29
PBT
0.23
0.29
1.08
1.43
-0.18
-0.98
-0.59
-0.09
0.71
0.21
0.2
0.26
-0.17
Tax %
82.61%
24.14%
27.78%
25.17%
-22.22%
0%
0%
0%
0%
23.81%
-35%
26.92%
-17.65%
Net Profit
0.04
0.23
0.79
1.07
-0.13
-0.97
-0.59
-0.09
0.71
0.15
0.27
0.2
-0.13
EPS (₹)
0.05
0.26
0.91
1.23
-0.15
-1.11
-0.68
-0.1
0.82
0.17
0.31
0.23
-0.15
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
2.79
5.26
6.1
9.78
11.28
5.04
4.81
4.45
4.19
Expenses
2.17
4.06
4.84
7.54
8.81
4.95
4.59
3.52
3.5
Operating Profit
0.62
1.2
1.26
2.24
2.47
0.09
0.22
0.93
0.69
OPM %
22.22%
22.81%
20.66%
22.9%
21.9%
1.79%
4.57%
20.9%
16.47%
Other Income
0.03
0.01
0
0
0
0
1.4
0.13
0
Interest
0.16
0.14
0.18
0.35
0.6
0.99
0.38
0.09
0.02
Depreciation
0.13
0.35
0.42
0.52
0.59
0.66
0.62
0.56
0.57
PBT
0.36
0.72
0.66
1.37
1.28
-1.56
0.62
0.41
0.1
Tax %
25%
26.39%
28.79%
26.28%
28.12%
0%
0%
-2.44%
30%
Net Profit
0.26
0.53
0.47
1.01
0.93
-1.56
0.62
0.42
0.06
EPS (₹)
0.44
0.61
0.54
1.16
1.07
-1.79
0.71
0.48
0.07
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.93
4.33
4.33
4.33
4.33
4.33
4.33
4.33
8.64
Reserves
0.4
3.73
4.21
5.22
6.15
4.59
5.21
5.62
5.5
Borrowings
1.88
0.9
1.76
4.04
5.15
6.4
3.48
4.07
2.06
Other Liabilities
1
1.18
1.63
1.61
2.49
2.4
1.97
1.72
1.4
Total Liabilities
6.21
10.14
11.93
15.2
18.12
17.72
14.99
15.74
17.6
Fixed Assets
2.06
3.28
3.47
5.24
5.75
5.39
3.99
3.51
3.27
CWIP
0
0
0
0
0
0
0
0
0
Investments
0.24
0.24
0.24
0.24
0.24
0.24
0.41
0.27
0.27
Other Assets
3.91
6.62
8.22
9.72
12.13
12.09
10.59
11.96
14.06
Total Assets
6.21
10.14
11.93
15.2
18.12
17.72
14.99
15.74
17.6
Figures in ₹ Crores

Cash Flow

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.58
-0.45
-0.1
1.19
2.01
0
-0.22
0.37
-0.76
Investing
-1.29
-1.95
-0.53
-2.26
-1.53
-0.2
1
0.06
-0.51
Financing
1.57
3.51
0.85
1.71
0.16
-0.23
-1.59
0.58
2.12
Net Cash Flow
0.85
1.12
0.23
0.64
0.64
-0.43
-0.81
1.01
0.84
Free Cash Flow
-0.73
-2.39
-0.71
-1.1
0.91
-0.3
0.74
0.3
-1.09
CFO/OP
94
-32
5
67
95
0
-100
40
-110
Figures in ₹ Crores

Ratios

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
149
127
199
149
137
360
357
431
532
Inventory Days
167
233
159
68.75
191
459
255
490
307
Days Payable
427
407
355
97.06
175
404
218
365
110
Cash Conversion Cycle
-111
-46.54
2.47
120
152
414
394
557
729
Working Capital Days
162
167
206
105
77.98
188
164
157
461
ROCE %
—
12.14%
8.72%
14.4%
12.87%
-3.68%
-2.68%
2.81%
0.79%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Dr Lalchandani Labs insights

57 extracted metrics + investor summaries across FY18–FY26.

Shareholding Pattern

Public62.74%Others4.35%Promot.32.90%As ofMar 2026

Documents

Frequently Asked Questions about Dr Lalchandani Labs

What does Dr Lalchandani Labs Ltd do?
Incorporated in 2011, Dr. Lalchandani Labs Ltd is in the business of running laboratories for pathological investigations[1]
Where is Dr Lalchandani Labs Ltd (DLCL) listed?
Dr Lalchandani Labs Ltd trades under code 541299 on the BSE.
Which sector does Dr Lalchandani Labs Ltd belong to?
Dr Lalchandani Labs Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd has a market capitalisation of ₹6.13 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Dr Lalchandani Labs Ltd?
Over the last 52 weeks Dr Lalchandani Labs Ltd has traded between ₹5.81 and ₹17.99 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd reported a return on equity of 4.19%. Its debt-to-equity ratio is 0.15.

Company Information

Incorporated in 2011, Dr. Lalchandani Labs Ltd is in the business of running laboratories for pathological investigations[1]

Website lalchandanipathlab.com
Listed 2018-05-09
Face Value ₹ 10
Shares Outstanding 86,71,329

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/541299.md for Dr Lalchandani Labs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month